Does creatine cause hair loss? The short answer
Current direct trial evidence does not demonstrate that creatine causes hair loss under specific conditions. A 2025 randomized, double-blind, placebo-controlled trial found no significant differences over 12 weeks in hair density, follicular unit count, cumulative hair thickness, or trichogram outcomes between healthy resistance-trained men taking 5 g/day of creatine monohydrate and those taking a placebo. The same study also recorded no significant changes in dihydrotestosterone (DHT) or testosterone measures compared to the control group.
This absence of demonstrated harm in a limited trial does not establish safety for every dose, population, or duration. The findings apply strictly to the specific parameters of that study: healthy men, 5 g/day, and a 12-week period. They do not prove that creatine can never affect hair under other circumstances, such as with higher doses, loading phases, longer use, or in individuals with preexisting hair-loss conditions. The association between creatine and hair loss largely stems from earlier research measuring circulating hormones rather than actual hair outcomes, creating a narrative gap that subsequent direct trials have begun to address but not fully close for all user groups.
Why creatine became associated with hair loss
The concern linking creatine to hair loss originated primarily from a small 2009 study involving 20 college-aged male rugby players. This double-blind, placebo-controlled crossover trial investigated the effects of creatine supplementation on hormone levels rather than hair health. The participants followed a regimen of 25 g/day with glucose for seven days, followed by 5 g/day for fourteen days.
The results showed that serum testosterone did not change, while DHT rose 56% from baseline after the loading phase and remained 40% above baseline during maintenance. The DHT-to-testosterone ratio also increased. DHT is an androgen known to play a role in shrinking hair follicles in individuals genetically predisposed to androgenetic alopecia. Because of this biological mechanism, the elevation in DHT sparked speculation that creatine might accelerate baldness.
The 2009 study measured only circulating hormones. It did not assess shedding, hair density, follicle condition, or clinical hair loss. An increase in serum DHT does not automatically translate to visible hair thinning or baldness, especially given that individual follicle sensitivity and other systemic factors vary widely. The leap from a hormonal shift in a specific athletic population to a general claim of hair loss represented an inference rather than an observed outcome, creating a lasting association that later studies sought to clarify.
What the latest direct hair-loss study found
To address the limitations of earlier hormone-only research, a 2025 randomized, double-blind, placebo-controlled trial was conducted as the first study designed to assess both androgen measures and direct hair-follicle outcomes. The trial assigned healthy resistance-trained men aged 18-40 to either creatine monohydrate at 5 g/day or a maltodextrin placebo for 12 weeks. Thirty-eight participants completed the full duration of the trial.
Researchers measured multiple parameters to evaluate hair health and hormonal status. These included serum DHT, testosterone levels, the DHT-to-testosterone ratio, hair density, follicular unit count, cumulative hair thickness, and trichogram outcomes (which track individual hair shaft characteristics). The analysis found no significant creatine-versus-placebo differences over time in any of these measures.
This result indicates that for this specific group-healthy men engaging in resistance training taking 5 g/day for three months-creatine did not alter the hormonal or physical indicators associated with hair loss. The trial's design and population restrict the generalizability of these findings. The outcome applies specifically to the dose, duration, and demographic tested. It resolves the immediate query for this group but does not extend to other scenarios such as long-term use beyond 12 weeks, different dosing strategies, or populations outside healthy young men.
What the evidence still cannot tell us
While the 2025 trial provides direct evidence against hair loss in a controlled setting, it leaves several critical questions unanswered due to its specific design and exclusions. The study lasted only 12 weeks, meaning long-term effects of creatine supplementation on hair health remain unestablished. It included only resistance-trained men, leaving the impact on women, adolescents, older adults, or non-athletic populations unknown.
The trial excluded individuals with diagnosed endocrine disorders, alopecia areata, thyroid disorders, relevant scalp conditions, or those who had undergone previous hair restoration procedures. Participants were also excluded if they had used creatine recently, taken anabolic-androgenic steroids, hormonal enhancers, finasteride, minoxidil, or other hair-growth supplements. These exclusions are methodologically sound for isolating the effect of creatine in a healthy baseline population, but they mean the findings cannot be confidently applied to people with existing hair-loss disorders or those undergoing treatment for them.
The study also did not assess family history of hair loss. Genetic predisposition is a primary driver of androgenetic alopecia, yet it remains unclear whether creatine might interact with genetic susceptibility to accelerate shedding in those prone to baldness. The 2009 finding of elevated DHT has not been disproven; rather, the 2025 trial showed that under its specific conditions, this hormonal shift (or lack thereof) did not manifest as hair loss. Without assessing genetics or longer timeframes, it is impossible to rule out effects in those who might be uniquely sensitive.
Creatine use when you already have thinning hair
For individuals already experiencing thinning hair, the decision to continue creatine supplementation involves navigating uncertainty rather than following established safety data. The direct trial findings cannot be confidently generalized to this group because the study explicitly excluded people with diagnosed hair-loss conditions, scalp disorders, and those using common hair-loss treatments. The reassuring results from healthy participants do not guarantee similar outcomes for those whose hair follicles are already compromised or undergoing active treatment.
People in this situation should distinguish between temporal coincidence and causation. Starting creatine does not automatically mean it is causing hair loss, especially given that male pattern baldness and other forms of alopecia often progress gradually regardless of supplementation. Rather than making an automatic decision to stop the supplement or initiating preventive treatments like finasteride or minoxidil solely due to creatine use, it is more prudent to document the pattern and timing of any changes.
If shedding increases or thinning accelerates after starting creatine, this observation should be recorded. Without clinical evaluation, it remains speculative whether creatine is the driver or if natural progression of hair loss is occurring simultaneously. There is no established protocol suggesting that stopping creatine will halt shedding or regrow hair, nor is there evidence that continuing it worsens outcomes in all cases of preexisting alopecia.
How to respond to new shedding or hair loss
Recognizing the pattern of hair loss is the first step in determining the appropriate response. Hair loss may appear as gradual thinning, a slowly enlarging bald spot, a receding hairline, a widening part, or a thinner ponytail. It can also occur suddenly, such as a bald patch or strip developing over one or two days. These patterns are signs requiring clinical interpretation rather than proof of a particular cause, such as creatine use. Appearance alone does not identify the underlying etiology.
If hair loss is sudden, dramatic, or patchy, evaluation by a dermatologist is advised. A dermatologist can distinguish excessive hair shedding from permanent hair loss and evaluate possible causes based on clinical judgment. Evaluation may include blood testing to check for nutritional deficiencies or hormone imbalances, or scalp biopsy if infection or specific dermatological conditions are suspected.
Stopping creatine cannot be promised to reverse hair loss because a creatine-related cause has not been established. Many factors contribute to hair thinning, including genetics, stress, diet, illness, and hormonal shifts. Assuming creatine is responsible without professional assessment may lead to unnecessary discontinuation of a safe supplement while overlooking treatable medical conditions. For any significant or unexplained changes in hair health, clinical evaluation remains the most reliable path to determining cause and appropriate management.